FMC

Q2 FY2026 EarningsQ2 FY26 missed consensus estimates on both top and bottom lines amid severe competitive pressure and pricing headwinds. Revenue of $867.1M fell short of the $897.1M expected, down 17% YoY, while normalized EPS of $0.26 (calculated from adjusted net income) was slightly above the $0.22 consensus but GAAP figures showed significant losses due to $222M in restructuring charges. North America and Asia saw the steepest declines at 22% and 20% respectively. Management's strategic pivot involves a $400M equity investment from Tessenderlo Group and a $200M licensing payment from Corteva to aggressively de-lever the balance sheet.